1800 202 8726
Managing your test bill

Limiting Your IHC Tests — to Control the Bill

Yes, you can ask for fewer IHC markers. The question is which ones you can safely skip and which ones will cost you more in the long run — through re-testing, a delayed diagnosis, or a treatment decision made without the full picture.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • Some markers are essential — Your oncologist cannot choose the right treatment without them.
  • Some markers can wait — Informational markers that do not change your immediate plan can often be deferred.
  • Cutting the wrong one costs more — A re-biopsy to retrieve a missed result is more expensive than the original test.
  • Have this conversation before the sample leaves — Once the tissue is at the lab, changing the order is difficult. Ask beforehand.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Find your nearest centre

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Yes, you can ask your oncologist to limit IHC markers — and a good oncologist will welcome the question. Some markers are essential for your diagnosis and treatment plan; others are informational. Skipping the wrong one, however, can mean a re-biopsy later, which costs more than the test you skipped.

What do IHC tests typically cost?

IHC test typeIndicative range (private lab)Notes
Single marker₹500 – ₹2,000Per marker; varies by lab, city, and tissue type
Standard 3-marker panel (e.g. for breast cancer)₹3,000 – ₹7,000The minimum for most breast cancer diagnoses
4-marker panel with proliferation index₹4,500 – ₹9,000Adds a tumour-grade marker; many oncologists consider this essential
Larger multi-marker solid tumour panel₹8,000 – ₹20,000+Varies by cancer type and the number of markers ordered
Repeat biopsy if tissue was insufficientProcedure cost plus new lab feesUsually more expensive than adequate testing at the first biopsy
Government / PMJAY ratesLower than private rates — confirm with your centreSpecific coverage and approved markers vary by state and scheme

Which markers are essential and which can you cut?

An essential marker is one your oncologist needs to make a treatment decision right now. Without it, they cannot tell you which therapy to use, whether you qualify for a targeted drug, or whether immunotherapy is relevant to your case.

An informational marker adds useful detail but does not change what happens this week. Skipping it does not leave your team unable to act today.

The risk of cutting an essential marker is not just a missed result. It can mean a delayed start to treatment, a re-biopsy if no tissue remains, and in some cases a therapy choice made without key information. That typically costs more than the marker itself — which is the cost argument for doing adequate testing the first time, not for doing less.

Which centre is right for you?

We have centres across Telangana and Andhra Pradesh. Tell us where you are and we will point you to the closest one that offers what you need.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Care closer to home

35+ centres, so most treatment does not mean relocating to a metro.

Book Free Consultation Call 1800 202 8726

What does each type of marker actually decide?

Marker purposeTypically essential at diagnosis?What happens if you skip it
Decides which systemic therapy you receiveYesTreatment cannot be correctly chosen; the wrong therapy is a real risk
Confirms the cancer type or subtypeYesThe diagnosis may be incomplete, affecting every decision that follows
Grades how aggressively the tumour is growingUsually essentialRisk of over- or under-treating the disease
Determines eligibility for immunotherapyEssential if immunotherapy is being considered for your caseYou may miss an eligible treatment, or need to re-test later at added cost
Tracks response on repeat testing after treatmentLess often needed at the first biopsyCan usually be deferred to a later assessment point
Prognostic markers not tied to a current treatment decisionNot always essentialGenerally safe to defer if cost is a constraint; confirm with your oncologist

How do you have this conversation with your oncologist?

  1. Raise it before the sample is sent

    Once the tissue leaves for the lab, changing the panel is difficult and sometimes impossible. Bring up cost concerns before the order is placed, not after.

  2. Ask for the list in two groups

    Ask your oncologist to separate markers into those needed to start treatment and those that are informational or can wait. Most oncologists can do this in a few minutes.

  3. Ask whether the tissue can support one run

    Small samples can be exhausted by a large panel. Your pathologist can advise whether the sample is adequate — prioritising essential markers protects what you have.

  4. Check your scheme or insurance before paying

    Many IHC markers are covered under PMJAY and some private insurance plans. Ask the billing team or a medical social worker at your centre to confirm coverage before you pay out of pocket.

  5. Agree on when deferred markers will be revisited

    If you and your oncologist agree to defer a marker, confirm the specific trigger — the point in treatment, or the circumstance, at which you would come back to it.

Did you know?

When tumour tissue is insufficient at the first biopsy — because the sample was small or was fragmented during processing — a repeat procedure is sometimes the only way to retrieve the missing result.

ESMO guidance on tumour tissue management identifies adequate collection at the first biopsy as a quality standard precisely because repeat procedures add delay, discomfort, and cost that typically exceed the original test.

Source: ESMO Recommendations on Tumour Tissue Collection and Biomarker Testing

Explore 71 more Understanding Your Biopsy and Whether You Need One topics

HUB — Does a Biopsy Spread Cancer? Myths and Evidence

HUB — What Is a Biopsy? Everything You Need to Know

All Understanding Your Biopsy and Whether You Need One →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Can I do the minimum panel now and add markers later if I need them?

Sometimes yes, but it depends entirely on whether enough tumour tissue remains after the first round of testing. Once a sample is consumed or exhausted, adding a marker means a new biopsy. Ask your pathologist how much tissue was collected and how much would remain after a targeted panel. That answer — not a general rule — determines whether deferral is a realistic option or a false economy.

Will PMJAY or private insurance cover IHC tests?

PMJAY covers a range of diagnostic tests and many IHC markers are included, though the approved list and ceiling vary by state and hospital empanelment. Private insurance plans differ significantly — some cover diagnostics within a hospitalisation claim, others require pre-authorisation. Ask the billing team or a medical social worker at your centre to verify your specific coverage before paying out of pocket; the markers you need most are often among those covered.

What happens if I skip a marker and my oncologist needs it later?

If stored tissue is still available, the lab can often run the missed marker on the original sample — though this adds time and a new lab fee. If the tissue has been exhausted, a repeat biopsy is the only option, at greater cost and discomfort. This is why doing adequate testing at the first biopsy is usually the more economical choice, even when the upfront bill looks large.

Is a cheaper private lab safe to use for IHC?

Accreditation matters more than price. Look for NABL accreditation — the National Accreditation Board for Testing and Calibration Laboratories — which sets quality standards for diagnostic labs in India. A result from an unaccredited lab may not be accepted by your oncologist, meaning you repeat the test at an accredited facility anyway. Ask your oncologist whether they have a preferred lab and why; the answer usually reflects the reliability of that lab's results.

How do I know if a marker is being ordered for my cancer or just as a routine panel?

Ask directly: 'Is this marker needed to decide my treatment, or is it informational?' A specific answer tied to your case is what you should expect. If the answer is 'we always order it' without a reason linked to your diagnosis, that is worth exploring further. Standard panels exist for good reasons, but your oncologist should be able to explain each marker's relevance to your specific cancer type.

Can we order certain markers only if the first-line treatment does not work?

For some markers, yes — particularly those that predict response to second- or third-line therapies. For others, deferring means delaying the treatment decision itself, which carries its own clinical cost. Your oncologist can tell you which markers in your panel fall into which group. That specific answer, based on your cancer type and stage, is the one to act on.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation